Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors
about
Oligodendroglioma: pathology, molecular mechanisms and markersAlterations of copy number of methylation pattern in mismatch repair genes by methylation specific-multiplex ligation-dependent probe amplification in cases of colon cancerThe global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for gliomaEGFR soluble isoforms and their transcripts are expressed in meningiomas.Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapiesThe combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone.SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomas.Chromogenic in situ hybridization is a reliable alternative to fluorescence in situ hybridization for diagnostic testing of 1p and 19q loss in paraffin-embedded gliomas.Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients.Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951Spectrum of EGFR gene copy number changes and KRAS gene mutation status in Korean triple negative breast cancer patients.The use of a two-tiered testing strategy for the simultaneous detection of small EGFR mutations and EGFR amplification in lung cancer.Detection of 1p19q deletion by real-time comparative quantitative PCR.Use of the MLPA assay in the molecular diagnosis of gene copy number alterations in human genetic diseases.Prevalence, clinico-pathological value, and co-occurrence of PDGFRA abnormalities in diffuse gliomas.The expression status of CD133 is associated with the pattern and timing of primary glioblastoma recurrence.EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy.Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor.Molecular diagnostics of gliomas: state of the art.Insights revealed by high-throughput genomic arrays in nonglial primary brain tumors.Molecular diagnostics: techniques and recommendations for 1p/19q assessment.Phenotypic and genotypic characterization of orthotopic human glioma models and its relevance for the study of anti-glioma therapy.Robust detection of EGFR copy number changes and EGFR variant III: technical aspects and relevance for glioma diagnosticsGenetic imbalances detected by multiplex ligation-dependent probe amplification in a cohort of patients with oral squamous cell carcinoma-the first step towards clinical personalized medicine.Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution.Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05).Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.IDH1/2 gene status defines the prognosis and molecular profiles in patients with grade III gliomas.Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma.The nature and timing of specific copy number changes in the course of molecular progression in diffuse gliomas: further elucidation of their genetic "life story".Benefits of interferon-β and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: A multicenter study.A novel method to detect the Mexican founder mutation BRCA1 ex9‑12del associated with breast and ovarian cancer using quantitative polymerase chain reaction and TaqMan® probes
P2860
Q27002448-B3299BBF-3186-42C5-B4A4-4758A257DB57Q28298882-9B05CCC4-B5FC-4EF5-BFD7-176790D09628Q28741768-51F09BAD-314F-4C38-8271-625DCD0D1A12Q31062214-59FD9E54-67B4-468A-B70C-081E87040BF5Q33925544-51072417-4BB5-45A7-9A81-C4538DB0BD40Q34061985-0BC2D906-A9E7-4BB6-BE01-16281744CD8CQ34446905-77367174-D1D6-4140-A4E0-6463147B4028Q34459510-C932F4C3-F94D-4A34-83FB-B9A8C309D795Q34722521-7D64A76A-4A33-4E81-AE54-8759D7776E5EQ34990522-E15AFACD-7BF6-4C97-834F-982E846A8B41Q35036895-C8D657DE-4F4A-422D-9073-3BE9A49808F0Q35125795-56703951-4DC5-41C1-8D7E-672091AE265BQ35789635-65AEF03D-E1CE-4811-A5CF-CEA2D8460579Q35866022-903B921E-0D5B-4999-8200-6136633DD8D7Q36344757-FB43FA41-0643-4C52-80C3-D39CCF304D62Q37109240-AB8083AD-FD9D-4E9F-AC2E-38DFB17EB66BQ37284362-5AEE4B6B-196A-46BA-8EBB-42632D501B94Q37432015-3DAA3872-1E68-4C39-A448-6D13866C8E3AQ37780495-3BB78CE2-E94B-464A-96C2-148B18AE9249Q37999071-BD607E2E-631D-40CF-AC3F-A919B1775240Q38627124-AD4E713B-45D6-4C9B-9965-A3E1385FD8B6Q39997794-375A2800-4D04-4C9E-8AF9-F519D71D2967Q41885614-73C1DE77-DE2A-4861-BE5A-4B189327B512Q42240179-65430F34-0304-4C5C-8A47-7B0E76D22EA7Q43411833-A01D2278-976C-479C-98B4-370DE2C1E49BQ43609687-3BF0393E-5780-4702-8173-F167D8382E62Q48166117-32095CB9-E5A1-4CC1-9BC0-46BD9CE047C5Q48860568-E8745F50-A27F-429E-9A96-FE11B781DC52Q54314557-B2177BE7-3A80-4C01-AAA5-7D3DBCD44BB3Q54637633-C3BA92E7-3C02-40D7-B859-CBC9C9315E7DQ55463256-B3194832-19A9-4B93-B819-61ECD010255FQ57173171-0079B12A-0EFB-4BE5-82F9-F3D0FD64EB62
P2860
Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Multiplex ligation-dependent p ...... enetic markers in glial tumors
@ast
Multiplex ligation-dependent p ...... enetic markers in glial tumors
@en
Multiplex ligation-dependent p ...... enetic markers in glial tumors
@nl
type
label
Multiplex ligation-dependent p ...... enetic markers in glial tumors
@ast
Multiplex ligation-dependent p ...... enetic markers in glial tumors
@en
Multiplex ligation-dependent p ...... enetic markers in glial tumors
@nl
prefLabel
Multiplex ligation-dependent p ...... enetic markers in glial tumors
@ast
Multiplex ligation-dependent p ...... enetic markers in glial tumors
@en
Multiplex ligation-dependent p ...... enetic markers in glial tumors
@nl
P2093
P2860
P1476
Multiplex ligation-dependent p ...... enetic markers in glial tumors
@en
P2093
Judith Jeuken
Sabine Gijsen
Sandra Boots-Sprenger
Sandra Cornelissen
P2860
P304
P356
10.2353/JMOLDX.2006.060012
P407
P577
2006-09-01T00:00:00Z